CSIMarket
 


Bridgebio Pharma Inc   (BBIO)
Other Ticker:  
 
 

Bridgebio Pharma Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Bridgebio Pharma Inc asset turnover ratio, the ability of Bridgebio Pharma Inc 's assets to generate revenue in the third quarter 2023, increased sequentially to 0.02 in the third quarter (Sep 30 2023), yet the ratio remained below the average, as BBIO's position remain challenging.

Within sector 215 more businesses have achieved higher asset turnover ratio. While Asset turnover ratio total ranking has improved so far during the III Quarter 2023, to 3535, from total ranking in the second quarter 2023 at 3739.


What is Asset Turnover Ratio?
What is Bridgebio Pharma Inc Market Share?


BBIO Asset Turnover Ratio (Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
Y / Y Asset Change -9.77 % -41.85 % -23.04 % -38.42 % -6.21 %
Y / Y Revenue Change 1110.36 % -97.77 % 7.79 % -85.49 % -85.58 %
Asset Turnover Ratio (TTM) 0.02 0.01 0.11 0.1 0.11
BBIO's Total Ranking # 3535 # 3739 # 3534 # 2151 # 3439
Seq. Asset Change 30.79 % -19.62 % 0.2 % -14.34 % -15.72 %
Seq. Revenue Change 149.3 % -10.13 % -2.35 % 453.25 % -99.54 %



Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 216
Healthcare Sector # 577
Overall Market # 3535

Asset Turnover Ratio Statistics
High Average Low
20.53 7.07 0.37
(Sep 30 2021)   (Jun 30 2023)







Companies with similar Asset Turnover Ratio for the quarter ending Sep 30 2023, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Sep 30 2023 Assets at quarter ending Sep 30 2023
Miromatrix Medical inc   0.04 $ 1.189  Millions$ 30.219  Millions
Armata Pharmaceuticals Inc   0.04 $ 4.052  Millions$ 104.647  Millions
Ambrx Biopharma Inc   0.04 $ 8.602  Millions$ 227.259  Millions
Intellia Therapeutics Inc   0.04 $ 51.765  Millions$ 1,376.148  Millions
Bolt Biotherapeutics Inc   0.04 $ 7.198  Millions$ 200.010  Millions
Pavmed Inc   0.04 $ 1.923  Millions$ 53.742  Millions
Stoke Therapeutics Inc   0.04 $ 9.248  Millions$ 258.668  Millions
Mirati Therapeutics Inc   0.04 $ 38.191  Millions$ 1,070.290  Millions
Enzon Pharmaceuticals inc   0.04 $ 1.648  Millions$ 46.938  Millions
Inovio Pharmaceuticals Inc   0.03 $ 9.057  Millions$ 260.313  Millions
Seer Inc   0.03 $ 16.095  Millions$ 466.691  Millions
Bluebird Bio Inc   0.03 $ 21.725  Millions$ 631.160  Millions
Xoma Corporation  0.03 $ 4.411  Millions$ 130.950  Millions
Abcellera Biologics Inc   0.03 $ 50.390  Millions$ 1,522.046  Millions
Vaxart Inc   0.03 $ 4.156  Millions$ 127.998  Millions
Ainos Inc   0.03 $ 1.140  Millions$ 35.431  Millions
Volitionrx Limited  0.03 $ 0.651  Millions$ 20.485  Millions
Bioaffinity Technologies Inc   0.03 $ 0.323  Millions$ 10.427  Millions
Therapeuticsmd Inc   0.03 $ 1.952  Millions$ 63.560  Millions
Cardiff Oncology inc   0.03 $ 2.968  Millions$ 102.162  Millions
Lumos Pharma Inc   0.03 $ 1.737  Millions$ 60.035  Millions
Anaptysbio Inc   0.03 $ 14.960  Millions$ 541.650  Millions
Nighthawk Biosciences inc   0.03 $ 2.227  Millions$ 86.504  Millions
Relay Therapeutics Inc   0.03 $ 25.553  Millions$ 1,001.577  Millions
Absci Corp  0.03 $ 6.937  Millions$ 276.828  Millions
Senti Biosciences Inc   0.02 $ 3.723  Millions$ 154.403  Millions
Astrotech Corp  0.02 $ 1.137  Millions$ 48.263  Millions
Janux Therapeutics Inc   0.02 $ 8.467  Millions$ 361.329  Millions
Checkpoint Therapeutics Inc   0.02 $ 0.171  Millions$ 7.436  Millions
Meiragtx Holdings Plc  0.02 $ 6.689  Millions$ 295.959  Millions

Date modified: 2023-11-03T15:57:06+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com